149 related articles for article (PubMed ID: 2465864)
41. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
Foti AG; Herschman H; Cooper JF
Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
[TBL] [Abstract][Full Text] [Related]
42. [Determination of acid phosphatase in prostatic carcinoma].
Bauer HW; Walther V; Schmiedt F
Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
[TBL] [Abstract][Full Text] [Related]
43. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
44. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
Cooper JF
Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
[TBL] [Abstract][Full Text] [Related]
45. [Changes in tumor markers following cryosurgery of prostate carcinoma].
Higaki Y; Imamura K
Hinyokika Kiyo; 1989 Feb; 35(2):265-70. PubMed ID: 2472049
[TBL] [Abstract][Full Text] [Related]
46. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
47. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
Tarle M; Kovacić K; Kastelan M
Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
[TBL] [Abstract][Full Text] [Related]
48. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
49. Histochemistry and quantitative microscopy of prostate cancer.
Bennett BD
Prog Clin Biol Res; 1987; 239():711-58. PubMed ID: 2443917
[No Abstract] [Full Text] [Related]
50. Biochemical markers in prostatic cancer.
Schacht MJ; Garnett JE; Grayhack JT
Urol Clin North Am; 1984 May; 11(2):253-67. PubMed ID: 6203205
[TBL] [Abstract][Full Text] [Related]
51. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
Hamami G
Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
[TBL] [Abstract][Full Text] [Related]
52. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
[TBL] [Abstract][Full Text] [Related]
53. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
54. Clinical diagnosis and staging of prostatic carcinoma.
Alcini E; D'Addessi A
Rays; 1993; 18(1):3-13. PubMed ID: 7689236
[No Abstract] [Full Text] [Related]
55. Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
Pappas AA; Gadsden RH
Ann Clin Lab Sci; 1984; 14(4):285-91. PubMed ID: 6465831
[TBL] [Abstract][Full Text] [Related]
56. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
[TBL] [Abstract][Full Text] [Related]
57. [Immunologic sperm detection].
Müller V; Hinkelmann G
Arch Kriminol; 1991; 188(3-4):106-9. PubMed ID: 1722088
[TBL] [Abstract][Full Text] [Related]
58. Biochemical and immunologic techniques for acid phosphatase measurement in the diagnosis of prostate cancer.
Chu TM
Natl Cancer Inst Monogr; 1978 Dec; (49):239. PubMed ID: 748777
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer?
Morote J; Ruibal A; Pascual C; Palou J; de Torres JA
J Urol; 1987 May; 137(5):891-3. PubMed ID: 2437332
[TBL] [Abstract][Full Text] [Related]
60. Prostatic secretory products as markers of prostatic neoplasms.
Purvis K; Mevåg B; Teige B; Torjesen P; Jakobsen H; Rui H; Attramadal A
APMIS Suppl; 1988; 2():224-37. PubMed ID: 2460112
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
